2026-06-30T04:06:59Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/113952025-03-26T12:58:13Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Vazquez-Moreno, Julio Alberto author Taha, MK author Findlow, J author Gupta, S author Borrow, Ray author 2016-10 The Global Meningococcal Initiative (GMI) is an international group of scientists and clinicians with recognized expertise in meningococcal disease including microbiology, immunology, epidemiology, public health and vaccinology. The GMI was established to promote the global prevention of meningococcal disease through education, research and international cooperation. The GMI held its second summit meeting in 2013 to discuss the different aspects of existing meningococcal immunization programmes and surveillance systems. Laboratory confirmation and characterization were identified as essential for informing evidence-based vaccine implementation decisions. The relative merits of different confirmatory methodologies and their applications in different resource settings were a key component of the discussions. This paper summarizes the salient issues discussed, with special emphasis on the recommendations made and any deficiencies that were identified. Epidemiol Infect. 2016 Oct;144(14):3052-3057. 10.1017/S0950268816001308 1469-4409 Epidemiology and infection 27357022 http://hdl.handle.net/20.500.12105/11395 Diagnosis GMI Meningitis Meningococcal disease Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease